ESTRO Guide 2019

“The training course is structured to be a condensed review of the most essential elements of IMRT treatments, touching a variety of subjects from theoretical and technical to more clinical topics.”

- Mahbod Sedaghat (Ph.D); Medical physicist, Radiotherapy dept.; Razavi Hospital -

METHODS OF ASSESSMENT • MCQ • Evaluation form.

and radiation oncologist • Immunotherapy and radiotherapy • Decision making • Endpoints in oncology • Radiotherapy and new drugs: what is known and what is not. Site specific lectures including practical case discussions • Head and neck cancer • Non small cell lung cancer • Small cell lung cancer • Breast cancer

ROADMAP

MULTIMODAL CANCER TREATMENT

KEYWORDS Radiotherapy, chemotherapy, combined modality, multidisciplinary approach, organ preservation, radiosensitisation, immunotherapy.

RADIATION ONCOLOGIST, OTHER SPECIALIST

FACULTY COURSE DIRECTOR

Barbara Jereczek-Fossa, Radiation Oncologist and Clinical Oncologist, European Institute of Oncology and University of Milan, Milan (IT)

FURTHER READING Please consult the ESTRO website page of this course for further information.

• Prostate cancer • Bladder cancer • Cervical cancer • Oesophageal cancer

TEACHERS • Giuseppe Curigliano, Medical Oncologist, European Institute of Oncology, Milan (IT) • Rob Glynne-Jones , Radiation Oncologist, Mount Vernon Centre for Cancer Treatment, London (UK) • Jesper Grau Eriksen, Clinical Oncologist, Odense University Hospital, Odense (DK) • Mario Levis, Radiation Oncologist, University of Turin, Turin (IT) • Martin Pruschy, Biologist, University Hospital Zürich, Zürich (CH) • Li Tee Tan, Consultant Oncologist, Cambridge University Hospital, NHS Trust, Cambridge (UK)

• Gastric cancer • Rectal cancer • Anal canal • Pancreas • Brain tumours • Lymphomas.

ACCREDITATION Application for CME recognition will be submitted to the European Accreditation Council for ContinuingMedical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

PREREQUISITES Before commencing this course participants should: • Be confident with the basic mechanisms of radiotherapy and systemic treatment in oncology • Know the basic principles of management of solid tumours • Know different ways of delivering chemotherapy/systemic therapy in combination with radiotherapy.

LOCAL ORGANISER Sung Hwan Kim, Radiation Oncologist, The Catholic University of Korea

TEACHINGMETHODS • 20 hours of lectures • 5 hours of case discussions

• Presentation and critical discussion of the available evidence, discussion of clinical cases.

Barbara Jereczek- Fossa

Korean Society for Radiation Oncology

61

SCHOOL